blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2419407

EP2419407 - IMPROVED PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.09.2013
Database last updated on 26.06.2024
Most recent event   Tooltip01.07.2016Lapse of the patent in a contracting state
New state(s): IS		published on 03.08.2016  [2016/31]
Applicant(s)For all designated states
Pharmathen S.A.
6, Dervenakion Str.
15351 Pallini Attikis / GR
[N/P]
Former [2012/08]For all designated states
Pharmathen S.A.
6, Dervenakion str.
15351 Pallini Attikis / GR
Inventor(s)01 / KOFTIS, Theoharis, V.
9th klm. Thessalonikis - Thermis
GR-57001 Thessaloniki / GR
02 / PANAGIOTIDIS, Theodoros
7 Papaflessa
GR-546 41 Thessaloniki / GR
03 / SONI, Rohit, Ravikant
9th klm. Thessalonikis - Thermis
GR-57001 Thessaloniki / GR
04 / LITHADIOTI, Alexandra
9th klm. Thessalonikis - Thermis
GR-570 01 Thessaloniki / GR
 [2012/15]
Former [2012/08]01 / KOFTIS, Theoharis, V.
6 Gripari
GR-542 48 Thessaloniki / GR
02 / PANAGIOTIDIS, Theodoros
7 Papaflessa
GR-546 41 Thessaloniki / GR
03 / SONI, Rohit, Ravikant
28 Solomou
GR-551 34 Kalamaria Thessaloniki / GR
04 / LITHADIOTI, Alexandra
7B, Grigoriou Lambraki
GR-570 01 Thermi Thessalonikis / GR
Representative(s)(deleted)
[2012/08]
Application number, filing date09776534.115.04.2009
WO2009EP02745
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010118757
Date:21.10.2010
Language:EN
[2010/42]
Type: A1 Application with search report 
No.:EP2419407
Date:22.02.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 21.10.2010 takes the place of the publication of the European patent application.
[2012/08]
Type: B1 Patent specification 
No.:EP2419407
Date:14.11.2012
Language:EN
[2012/46]
Search report(s)International search report - published on:EP21.10.2010
ClassificationIPC:C07D209/24
[2012/08]
CPC:
C07D209/24 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/08]
Extension statesAL30.09.2011
BA30.09.2011
RS30.09.2011
TitleGerman:VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON FLUVASTATIN UND SALZEN DAVON[2012/08]
English:IMPROVED PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF[2012/08]
French:PROCÉDÉ AMÉLIORÉ DE PRÉPARATION DE FLUVASTATINE ET DE SELS DE CELLE-CI[2012/08]
Entry into regional phase30.09.2011National basic fee paid 
30.09.2011Designation fee(s) paid 
30.09.2011Examination fee paid 
Examination procedure14.10.2011Amendment by applicant (claims and/or description)
14.10.2011Examination requested  [2012/08]
23.08.2012Communication of intention to grant the patent
13.09.2012Fee for grant paid
13.09.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.08.2012
Opposition(s)15.08.2013No opposition filed within time limit [2013/43]
Fees paidRenewal fee
30.09.2011Renewal fee patent year 03
23.03.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
IS14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
MK14.11.2012
MT14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
TR14.11.2012
BG14.02.2013
NO14.02.2013
IE15.04.2013
LU15.04.2013
CH30.04.2013
LI30.04.2013
[2016/31]
Former [2015/34]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
MK14.11.2012
MT14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
TR14.11.2012
BG14.02.2013
NO14.02.2013
IE15.04.2013
LU15.04.2013
CH30.04.2013
LI30.04.2013
Former [2015/32]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
MK14.11.2012
MT14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
TR14.11.2012
BG14.02.2013
NO14.02.2013
IE15.04.2013
CH30.04.2013
LI30.04.2013
Former [2015/13]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
MT14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
IE15.04.2013
CH30.04.2013
LI30.04.2013
Former [2014/20]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
IE15.04.2013
CH30.04.2013
LI30.04.2013
Former [2014/08]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
CH30.04.2013
LI30.04.2013
Former [2014/01]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
MC14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
Former [2013/52]AT14.11.2012
BE14.11.2012
CY14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
Former [2013/37]AT14.11.2012
BE14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
NL14.11.2012
PL14.11.2012
RO14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
Former [2013/35]AT14.11.2012
BE14.11.2012
CZ14.11.2012
DK14.11.2012
EE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
PL14.11.2012
SE14.11.2012
SI14.11.2012
SK14.11.2012
BG14.02.2013
NO14.02.2013
Former [2013/34]AT14.11.2012
BE14.11.2012
DK14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
PL14.11.2012
SE14.11.2012
SI14.11.2012
BG14.02.2013
NO14.02.2013
Former [2013/31]AT14.11.2012
BE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
PL14.11.2012
SE14.11.2012
SI14.11.2012
NO14.02.2013
Former [2013/27]BE14.11.2012
FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
PL14.11.2012
SE14.11.2012
SI14.11.2012
NO14.02.2013
Former [2013/26]FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
PL14.11.2012
SE14.11.2012
SI14.11.2012
NO14.02.2013
Former [2013/23]FI14.11.2012
HR14.11.2012
LT14.11.2012
LV14.11.2012
PL14.11.2012
SE14.11.2012
NO14.02.2013
Former [2013/22]FI14.11.2012
LT14.11.2012
SE14.11.2012
NO14.02.2013
Former [2013/21]LT14.11.2012
SE14.11.2012
NO14.02.2013
Former [2013/20]LT14.11.2012
NO14.02.2013
Cited inInternational search[A]WO2004113291  (TEVA PHARMA [IL], et al) [A] 1-14 * page 1, line 19 - line 37 * * page 25 - page 34; examples 2-5,1822,24,25,27-32,38 * * claim 10 * * claim 12 *;
 [A]EP1847529  (ITALIANA SINT SPA [IT]) [A] 1-14 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.